{
    "clinical_study": {
        "@rank": "82155", 
        "acronym": "HREVS", 
        "arm_group": [
            {
                "arm_group_label": "Hybrid group", 
                "arm_group_type": "Other", 
                "description": "Hybrid approach (Minimally invasive off-pump revascularization of the left anterior descending artery (LAD) with the left internal mammary artery (LIMA) bypass followed by consecutive percutaneous coronary intervention (PCI) in the rest of the arteries with drug eluting stents (DES) (Hybrid group, n=50)"
            }, 
            {
                "arm_group_label": "PCI", 
                "arm_group_type": "Other", 
                "description": "Multi-vessel PCI with DES (MV-PCI group, n=50)"
            }, 
            {
                "arm_group_label": "CABG", 
                "arm_group_type": "Other", 
                "description": "Coronary artery bypass graft (CABG) treatment (CABG group, n=50)"
            }
        ], 
        "brief_summary": {
            "textblock": "Minimally invasive revascularization of the left anterior descending artery followed by\n      stent implantation versus percutaneous coronary intervention or coronary artery bypass in\n      patients with multi-vessel coronary disease"
        }, 
        "brief_title": "The Comparative Effectiveness of Hybrid Revascularization (MIDCAB Then PCI) With DES Versus Multivessel DES PCI or CABG", 
        "completion_date": {
            "#text": "December 2018", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Coronary Artery Disease", 
            "Myocardial Ischemia", 
            "Coronary Disease", 
            "Heart Diseases"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Coronary Artery Disease", 
                "Myocardial Ischemia", 
                "Coronary Disease", 
                "Heart Diseases", 
                "Ischemia"
            ]
        }, 
        "detailed_description": {
            "textblock": "Prospective, single-center, randomized trial, intended to compare three revascularization\n      strategies in patients with multi-vessel coronary artery disease:\n\n        1. Hybrid approach (Minimally invasive off-pump revascularization of the left anterior\n           descending artery (LAD) with left internal mammary artery (LIMA) bypass followed by\n           consecutive percutaneous coronary intervention (PCI) in the rest of the arteries with\n           drug eluting stents (DES) (Hybrid group, n=50)\n\n        2. Multi-vessel PCI with DES (MV-PCI group, n=50)\n\n        3. Coronary artery bypass graft (CABG) treatment (CABG group, n=50)\n\n      PCI in Hybrid and MV-PCI group will be performed with the same 2nd generation clinically\n      proven DES (Xience V, Xience Prime).\n\n      Study objective Compare three different revascularization strategies in patients with\n      multi-vessel coronary disease\n\n      The endpoints: The primary endpoints will be death, MI, stroke, or new myocardial ischemia\n      and  will be TVR and non-TVR at 30 days, 12 months and 5-year follow-up.\n\n      The secondary endpoints: Procedural success, Procedural and post-procedural blood loss and\n      number of transfusions, Recovery time, Heart Failure (New York Heart Association (NYHA)),\n      life quality assessed by one of the life quality questionnaires"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Multi-vessel coronary artery disease with \u2265 70% and <96% artery stenosis (according\n             to QCA)\n\n          2. I-IV CCS functional class of angina\n\n          3. Asymptomatic patients with stress-test documented ischemia.\n\n          4. Patients at 1 month after acute myocardial infarction\n\n          5. Ability to perform either of revascularization methods (Hybrid, MVD-PCI, CABG).\n\n          6. Consensus on the treatment strategy between the members of the working group,\n             including cardiologist, cardiac surgeon and interventional specialist.\n\n          7. Patients must have signed an informed consent.\n\n        Exclusion Criteria:\n\n          1. Pregnancy.\n\n          2. Acute coronary syndrome.\n\n          3. Previous CABG.\n\n          4. Previous stent thrombosis.\n\n          5. Severe comorbidity with high procedural risk for either of the studied strategies.\n\n          6. Severe peripheral artery disease.\n\n          7. Other serious diseases limiting life expectancy (e.g. oncology)\n\n          8. Inability for long-term follow-up.\n\n          9. Participation in other clinical trials.\n\n         10. Inability to take dual antithrombotic therapy.\n\n        Angiographic exclusion criteria\n\n          1. Critical stenosis (\u226595%) in RCA,LAD, CX or Intermediate artery, feasible for\n             revascularization.\n\n          2. Left main lesions.\n\n          3. Coronary artery occlusion of the major vessel.\n\n          4. Single vessel disease.\n\n          5. Need for emergency revascularization (Acute MI, ACS etc.)."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "150", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 1, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01699048", 
            "org_study_id": "HREVS"
        }, 
        "intervention": [
            {
                "arm_group_label": "Hybrid group", 
                "description": "Hybrid approach (Minimally invasive of-pump revascularization of the left anterior descending artery (LAD) via left internal mammary artery (LIMA) bypass with consecutive percutaneous coronary intervention (PCI) in the rest arteries with drug eluting stents (DES). The revascularization will be performed in two stages within a 3-days interval", 
                "intervention_name": "Hybrid (MIDCAB+PCI)", 
                "intervention_type": "Procedure", 
                "other_name": "MIDCAB"
            }, 
            {
                "arm_group_label": "PCI", 
                "description": "Multi-vessel PCI with DES", 
                "intervention_name": "PCI", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "CABG", 
                "description": "Coronary artery bypass graft (CABG) treatment", 
                "intervention_name": "CABG", 
                "intervention_type": "Procedure"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": "CAD,PCI,MIDCAB,CABG", 
        "lastchanged_date": "October 4, 2012", 
        "location": {
            "contact": {
                "email": "ganyukov@mail.ru", 
                "last_name": "Vladimir I Ganyukov, MD", 
                "phone": "+79131273905"
            }, 
            "contact_backup": {
                "email": "drpopov@mail.ru", 
                "last_name": "Vadim A Popov, MD", 
                "phone": "+79134332444"
            }, 
            "facility": {
                "address": {
                    "city": "Kemerovo", 
                    "country": "Russian Federation", 
                    "state": "Kemerovo region", 
                    "zip": "650002"
                }, 
                "name": "Research Institute of Complex Issues of Cardiovascular Diseases"
            }, 
            "investigator": [
                {
                    "last_name": "Vadim A Popov, MD", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Vladimir I Ganyukov, MD", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Alexander A Shilov, MD", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Russian Federation"
        }, 
        "number_of_arms": "3", 
        "official_title": "Prospective, Single-center, Randomized Trial, Intended to Compare Three Revascularization Strategies in Patients With Multi-vessel Coronary Artery Disease", 
        "overall_contact": {
            "email": "ganyukov@mail.ru", 
            "last_name": "Vladimir I Ganyukov, MD", 
            "phone": "+79131273905"
        }, 
        "overall_contact_backup": {
            "email": "drpopov@mail.ru", 
            "last_name": "Vadim A Popov, MD", 
            "phone": "+79134332444"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Russia: Ministry of Health of the Russian Federation", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Major adverse cardiac and cerebral events (MACCE), including death,a composite of major cardiac and cerebrovascular events, i.e. the first occurrence of any of the following events:\nDeath from any cause From cardiovascular causes From noncardiovascular causes\nStroke or transitory ischemic attack (TIA) MI Hospitalization for repeat revascularization procedure,  target (vessel) revascularization by means of PCI or CABG.", 
            "measure": "MACCE", 
            "safety_issue": "Yes", 
            "time_frame": "up to 5 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01699048"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Russian Academy of Medical Sciences", 
            "investigator_full_name": "Dr. Vladimir Ganyukov", 
            "investigator_title": "Hybrid minimally invasive and Interventional coronary revascularization in patients with Multi-vessel coronary artery disease versus complete Endovascular Revascularisation or coronary Artery bypass graft (treatment strategies).", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Procedural success: The treatment will be considered successful when a complete hybrid revascularisation in the absence of complications during the index hospitalization has been achieved.", 
                "measure": "Procedural success", 
                "safety_issue": "Yes", 
                "time_frame": "up to discharge from the hospital"
            }, 
            {
                "measure": "Procedural and post-procedural blood loss and number of transfusions", 
                "safety_issue": "Yes", 
                "time_frame": "up to discharge from the hospital"
            }, 
            {
                "description": "Time Frame: from the end of the intervention up to discharge from the hospital. Total duration of hospital admission", 
                "measure": "Recovery time", 
                "safety_issue": "Yes", 
                "time_frame": "up to discharge from the hospital"
            }, 
            {
                "measure": "\u2022 New York Heart Association (NYHA) class modification with respect to baseline", 
                "safety_issue": "No", 
                "time_frame": "up to 5 years"
            }, 
            {
                "measure": "life quality assessed by one of the life quality questionnaires", 
                "safety_issue": "No", 
                "time_frame": "up to 5 years"
            }
        ], 
        "source": "Russian Academy of Medical Sciences", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Russian Academy of Medical Sciences", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "October 2012"
    }
}